Opinion

University General Hospital LP and Ascension Physician Solutions, LLC v. Prexus Health Consultants, LLC and Prexus Health, LLC

  • 403 S.W.3d 547
  • 2013 Tex. App. LEXIS 7462
  • 2013 WL 3312358
Court
Texas Court of Appeals, 14th District (Houston)
Filed
Jun 20, 2013
Status
Published
Author
Busby
On the bench
Frost, Boyce, Busby
Cited by
48 cases
Authority
More cited than 80.0%

concluding evidence insufficient to support lost-profits damages because, among other reasons, there was no evidence the contract on which plaintiff would earn a 32% profit margin was sufficiently similar to the terminated contracts such that plaintiff “would earn the same profit margin on all three of them”

How later courts described this case

  • concluding evidence insufficient to support lost-profits damages because, among other reasons, there was no evidence the contract on which plaintiff would earn a 32% profit margin was sufficiently similar to the terminated contracts such that plaintiff “would earn the same profit margin on all three of them”
  • stating that when an appellant attacks the legal sufficiency of an adverse finding on an issue on which it did not have the burden of proof, it must demonstrate on appeal that there is no evidence to support the adverse finding
  • describing lost profit as the loss of net income to a business, that is, income for lost business activity less any expenses that would have been attributable to that activity
  • rejecting pro forma as a basis for awarding damages

Written by the judges who cited it.

The opinion

Affirmed as Modified and Substitute Opinion filed June 20, 2013.

In The

Fourteenth Court of Appeals

NO. 14-11-00988-CV

UNIVERSITY GENERAL HOSPITAL, LP AND ASCENSION PHYSICIAN

SOLUTIONS, LLC, Appellants

V.

PREXUS HEALTH CONSULTANTS, LLC AND PREXUS HEALTH, LLC,

Appellees

On Appeal from the 270th District Court

Harris County, Texas

Trial Court Cause No. 2009-77474

SUBSTITUTE OPINION

We issued an opinion in this case on April 2, 2013, modifying the trial

court’s judgment to delete awards of lost profit damages and affirming the

judgment as modified. Appellees subsequently filed a motion for rehearing.

Without changing the disposition of the case, we deny the motion for rehearing,

withdraw our previous opinion, and issue this substitute opinion.

Appellants University General Hospital, LP (“University General”) and

Ascension Physician Solutions, LLC (“Ascension”) appeal from a judgment

rendered against them following a jury trial. Concluding that there is legally

insufficient evidence to support the jury’s awards of lost profit damages, we

modify the trial court’s judgment to delete those awards and affirm the judgment as

modified.

BACKGROUND

Appellees Prexus Health Consultants, LLC and Prexus Health, LLC

(collectively “Prexus”) provide healthcare management, administrative support,

and consulting services to hospitals such as University General. On March 2,

2009, University General entered into a Professional Services Agreement (“PSA”)

with Prexus. Pursuant to the PSA, Prexus would provide three distinct services to

University General: medical transcription, medical coding, and billing. On that

same day, Ascension, which was responsible for the day-to-day operation of

University General, entered into a Consulting Services Agreement (“CSA”) with

Prexus. Through the CSA, Prexus agreed to provide various consulting services

related to the daily operation of University General. The term of both the PSA and

the CSA was three years, with both expiring on March 2, 2012.1

On September 8, 2009, University General and Ascension terminated both

the PSA and the CSA. In December 2009, Prexus filed suit against University

1

Both the PSA and the CSA contain choice-of-law clauses providing that they are to be

governed by Ohio law. Neither side has raised an issue on appeal addressing the choice-of-law

clauses or arguing that Ohio law conflicts with Texas law. Thus, we need not address any

choice-of-law issue, and we apply Texas law. See 1993 GF P’ship v. Simmons & Co. Int’l., No.

14-09-00268-CV, 2010 WL 4514277, at *9 n.15 (Tex. App.—Houston [14th Dist.] November 9,

2010, no pet.) (mem. op.).

2

General, Ascension, and numerous other defendants not parties to this appeal.

Prexus alleged University General had breached the PSA and Ascension had

breached the CSA. Prexus sought damages for unpaid invoices for work already

performed as well as damages for lost profits Prexus allegedly would have earned

during the two-and-a-half years remaining under both agreements. The lawsuit

went to trial before a jury on April 11, 2011.

The jury found that University General breached the PSA. The jury then

determined that University General owed Prexus $146,000 for work already

performed under the PSA and that Prexus suffered $900,000 in lost profits as a

result of University General’s breach. The jury also found that Ascension

breached the CSA. The jury found that Ascension owed Prexus $608,005 for work

already performed pursuant to the CSA and determined that Prexus experienced

$1,200,000 in lost profits as a result of Ascension’s breach. Finally, the jury

determined that Prexus’s reasonable and necessary attorneys’ fees through trial

were $107,000.

Contending the evidence was insufficient to support the award of lost profits

under either contract, appellants moved for judgment notwithstanding the verdict.

The trial court denied appellants’ motion and rendered judgment in accordance

with the jury’s verdict. This appeal followed.

ANALYSIS

Appellants’ three issues on appeal challenge only the portion of the trial

court’s final judgment awarding Prexus lost profits. Because it is dispositive of

this appeal, we need only reach appellants’ second issue, in which appellants

contend the evidence is legally insufficient to support the jury’s awards of lost

profits under the PSA and the CSA.

3

I. Standard of review

If an appellant attacks the legal sufficiency of an adverse finding on an issue

on which it did not have the burden of proof, the appellant must demonstrate on

appeal that there is no evidence to support the adverse finding. Price Pfister, Inc.

v. Moore & Kimmey, Inc., 48 S.W.3d 341, 347 (Tex. App.—Houston [14th Dist.]

2001, pet. denied). In conducting a legal sufficiency review, we must consider the

evidence in the light most favorable to the appealed finding and indulge every

reasonable inference that supports it. 2900 Smith, Ltd. v. Constellation

NewEnergy, Inc., 301 S.W.3d 741, 745 (Tex. App.—Houston [14th Dist.] 2009, no

pet.) (citing City of Keller v. Wilson, 168 S.W.3d 802, 821–22 (Tex. 2005)). The

evidence is legally sufficient if it would enable reasonable and fair-minded people

to reach the decision under review. Id. This court must credit favorable evidence

if a reasonable trier of fact could, and disregard contrary evidence unless a

reasonable trier of fact could not. Id. The trier of fact is the sole judge of the

witnesses’ credibility and the weight to be given their testimony. Id.

This court may sustain a legal sufficiency (or no evidence) issue only if the

record reveals one of the following: (1) the complete absence of evidence of a vital

fact; (2) the court is barred by rules of law or evidence from giving weight to the

only evidence offered to prove a vital fact; (3) the evidence offered to prove a vital

fact is no more than a scintilla; or (4) the evidence established conclusively the

opposite of the vital fact. Id. at 745–46. Evidence that is so weak as to do no more

than create a mere surmise or suspicion that the fact exists is less than a scintilla.

Kellmann v. Workstation Integrations, Inc., 332 S.W.3d 679, 684 (Tex. App.—

Houston [14th Dist.] 2010, no pet.).

4

II. Prexus’s awards of lost profit damages are not supported by legally

sufficient evidence.

Lost profits are damages for the loss of net income to a business. Miga v.

Jensen, 96 S.W.3d 207, 213 (Tex. 2002). Broadly speaking, they reflect income

from lost business activity, less any expenses that would have been attributable to

that activity. Kellmann, 332 S.W.3d at 684. While the recovery of lost profits

does not require that the loss be susceptible of exact calculation, the party seeking

such damages must do more than show that it suffered some lost profits. ERI

Consulting Eng’rs, Inc. v. Swinnea, 318 S.W.3d 867, 876 (Tex. 2010) (quoting

Holt Atherton Indus., Inc. v. Heine, 835 S.W.2d 80, 84 (Tex. 1992)). The amount

of the loss must be shown by competent evidence with reasonable certainty. Id.

A party seeking lost profit damages need not produce documentary evidence

in court supporting an award, but any opinions or estimates of damages must be

based on objective facts, figures, or data from which the amount of lost profits can

be ascertained. Id. Conclusory or speculative evidence of lost profits cannot

support an award. See Szczepanik v. First S. Trust Co., 883 S.W.2d 648, 649–50

(Tex. 1994). A party seeking lost profit damages must demonstrate one complete

calculation of lost profits. Kellmann, 332 S.W.3d at 684. That calculation must be

based on net profits, not gross revenue or gross profits. Id.

A. The evidence regarding lost profits

The judgment awards Prexus $900,000 in lost profits from the PSA and $1.2

million in lost profits from the CSA. In their second issue, appellants contend that

the evidence is legally insufficient to support either award under the legal

standards discussed above. Considering the evidence in the light most favorable to

the awards, there were at most two witnesses who testified on the issue of Prexus’s

alleged lost profit damages: Dr. Ajay Mangal and Mike Griffin. Both testified as

5

fact witnesses, not experts.

Mangal testified that, in addition to being an ear, nose, and throat doctor, he

is a partial owner as well as the Chief Executive Officer (“CEO”) of Prexus.

Mangal also testified that he was serving as the CEO of Prexus in 2009. Mangal

informed the jury he had an MBA in general business. While he testified about

numerous subjects during the trial, Mangal’s testimony eventually turned to the

subject of Prexus’s lost profit damages. Mangal began his testimony on this

subject by explaining that he was quite familiar with and worked closely with the

company’s financials, reviewing them before presentations to the board and

analyzing pro formas for any new projects.

A bench conference then occurred during which the trial court, after

ascertaining that Mangal had not been designated as an expert, ruled that Mangal

would not be allowed “to offer any expert testimony about any damage model.”

Mangal then continued with his testimony.

Q. Ajay, you have written some numbers on this chart, how

has Prexus been damaged by [University General]

terminating the PSA?

[Mangal]. I can speak in basic terms that I looked at the numbers,

the PSA and CSA. And over three years, . . .

[Objection and ruling omitted]

[Mangal]. It would have - - just the revenue number would have

been about $8 million revenue. Okay. That is not profit,

just revenue, what we would have billed [University

General] for those contracts and for the services for the

three years.

And our profit margin or contribution margin being - -

[Counsel]. Your honor, I also object that he is about to get into

expert testimony.

6

The Court. Sustained.[2]

Q. Ajay, how much money have you lost as a result of

defendant’s breach of the PSA and the CSA?

[Objection and ruling omitted]

[Mangal]. About $2.4 million over three years.

[Objections and rulings omitted]

Q. So when you say three years, you mean the two and a

half years remaining on the contract, correct?

[Mangal]. Absolutely.

Q. How did you get that number?

...

[Mangal]. We look at the revenue that is lost and so we know the

income that is lost from new contracts. And that is what

I have to, as the CEO, look at that data and see what, you

know, each contracts [sic] means to us as a company.

...

Q. All right. So for the damages for the breach of contract

by [University General] and Ascension, what would

those damages include?

[Mangal]. They would include loss of PSA and CSA for about two

and a half years.

Q. Okay. And what are the numbers?

[Objections and rulings omitted]

[Mangal]. $2.4 million.

Mangal’s testimony then turned to a potential agreement Prexus was

negotiating with Humble Surgical Hospital (“Humble Hospital”), a planned new

hospital in the northern part of Harris County. Prexus would later argue that the

expected profit margin on this potential agreement could be used to calculate lost

profits under the PSA and CSA. Mangal’s testimony focused on a pro forma

2

On appeal, Prexus does not challenge any of the trial court’s evidentiary rulings.

7

projecting the income Prexus expected to earn if the negotiations with Humble

Hospital proved successful and Humble Hospital came into existence.

Q. When you need to make sure it is profitable, is one thing

you do is look at a pro forma to determine what you

would expect to make in future years once you perform

the contract?

[Mangal]. That’s correct.

Q. And from - - how do you look at a pro forma to

determine that?

[Mangal]. Look at the income and expenses and the bottom line.

...

Q. Sorry, Ajay. As Prexus’ CEO, did you do this in

evaluating the Humble Hospital project?

[Mangal]. Yes.

Q. And with whom did you participate in this effort with

Prexus?

[Mangal]. Initially, Mike Griffin and Jerry Fye.

Q. Exhibit 35, which is the pro forma, does it show the

money that Prexus was to make over three years?

[Mangal]. Yes.[3]

Q. And what does it say?

[Mangal]. We were expecting to collect about $13 million.

Mangal’s testimony later turned back to the Humble Hospital negotiations.

Q. Ajay, a while ago when you testified about the 13

million, is the 13 million your profit from the project?

[Mangal]. No, that is the revenue that we would have gotten from

three years of the CSA and the PSA.

Q. What is your profit?

3

Plaintiff’s Exhibit 35 is a document entitled: “Humble Surgical Hospital-Business

Model and Assumptions.”

8

[Counsel]: Objection, Your Honor. He is not qualified to give that

testimony.

The Court: Sustained.

Q. You have testified that in your role as CEO, you know

what your revenues are, correct?

[Mangal]. That’s correct.

At that point, Prexus passed the witness. Following appellants’ cross-

examination, Prexus resumed questioning Mangal the next day. Once again, the

questions were directed at the revenue and profit expected if the Humble Hospital

negotiations proved successful.

Q. Yesterday, you told the jury through this Exhibit 35 that

Prexus expected to make 13 million in revenue from

[Humble Hospital]; do you remember that?

[Mangal]. Yes.

Q. Ajay, what is your profit margin on that revenue?

[Counsel]: Objection, Your Honor, foundation, and also object on

the grounds that his testimony was not timely disclosed

in discovery.

The Court: Overruled.

[Mangal]. 32 percent based on our last year data.

Q. I’m sorry, based on what?

[Mangal]. Last year financials.

Mike Griffin was the second witness whose testimony touched on the issue

of Prexus’s lost profits damages. Griffin served as Prexus’s Chief Financial

Officer and later left to help found another company that provides management

services to University General.

While Griffin testified on many subjects, he was also asked about Prexus’s

alleged lost profit damages.

9

Q. Won’t [sic] don’t you pull up, if you will - - if you’ll go

to Plaintiff’s Exhibit No. 35. Exhibit No. 35, this is a

proforma, I think you’ve heard about a little while ago

that was prepared between Prexus and Humble Surgical

Hospital; do you recall that?

[Griffin]. Yes.

Q. Okay. And - - and I think Ajay’s testimony was that you

didn’t ultimately prepare this exhibit 35, but you

prepared the majority of the iteration that led to this, do

you recall that?

[Griffin]. Yeah, I helped, definitely.

Q. In fact, you prepared a lot of these numbers and

projections; isn’t that correct?

[Griffin]. I can’t answer that 100 percent. I did a proforma for the

project.

Q. Right.

[Griffin]. But I don’t know if this was the final and if the numbers

were changed and whatnot, but I did definitely do a

proforma.

...

Q. There are some numbers there on that page. And if you

add up some of those numbers, you come up with a

number around $13 million. You heard Ajay testify to

that yesterday?

[Griffin]. Yeah. I don’t know where he’s getting this number.

Q. Look, if you will, at . . . the first three columns in Lines 3

through 5. Those would be part of the anticipated

revenues. In other words, if you look at . . . transcription

services, coding services and billing services for the three

years, you would add those numbers together - -

[Griffin]. Got it.

Q. - - to determine revenue for Prexus, correct?

[Griffin]. Got it.

Q. Is that - - do you agree with that?

10

[Griffin]. Yes.

...

Q. Okay. And - - and in order to determine what profit

Prexus would have made, you would have had to - - you

have to apply a profit margin, right?

[Griffin]. That’s correct.

Q. Okay. So whatever the profit margin is times the $13

million, that equals the amount of revenue that Prexus

would have - - was supposed to have received according

to the proformas from the [Humble Hospital] contract.

[Griffin]. Right.

...

Q. Now, with respect to the damages that Prexus has

suffered, . . . you heard the testimony from Ajay that the

calculation for the two and a half years remaining on the

contract was $2.4 million. You heard that, correct?

[Griffin]. For revenue.

...

Q. You heard Ajay’s testimony that the amount of money

that Prexus lost on the remaining two and a half years on

the PSA and the CSA with [University General] was $2.4

million.

[Griffin]. Yes, I did.

Q. Okay. That was profit, correct, it’s not revenue?

[Griffin]. I did factor that.

Q. And do you disagree with that?

[Griffin]. I don’t know the answer. I wouldn’t - - I wouldn’t be

able to tell you that number.

B. This evidence is legally insufficient to support any lost profit

damages.

We conclude that this evidence is legally insufficient to support awards of

lost profit damages to Prexus. As explained above, the plaintiff seeking lost profits

11

damages bears the burden of providing a single complete calculation of lost profits,

which reflects revenue from lost business activity less expenses that would have

been attributable to that activity. Kellmann, 332 S.W.3d at 684. Prexus did not

provide that calculation here. With respect to revenue, although documentary

evidence is not required, Mangal’s testimony includes no objective facts, figures,

or data explaining how he arrived at his $8 million anticipated revenue figure. See

Szczepanik, 883 S.W.2d at 650 (“There is nothing in the record to show how [the

appellee] determined the amount of lost profits.”); Holt Atherton, 835 S.W.2d at 84

(“[T]his testimony is legally insufficient because it does not provide any indication

of how the Heines determined what their lost profits were.”); see also Glattly v. Air

Starter Components, Inc., 332 S.W.3d 620, 635 (Tex. App.—Houston [1st Dist.]

2011, pet. denied) (holding evidence of lost profits was legally insufficient because

it did not establish that calculation was based on objective facts, figures, or data).

Mangal also did not discuss expenses, though he testified that Prexus “lost”

$2.4 million as a result of appellants’ breach of both the PSA and the CSA. It is

far from clear that this figure represents lost profits (revenue minus expenses), but

even if we assume it does, Mangal once again did not provide any objective facts,

figures, or data explaining how he arrived at that amount. When asked how, he

said that “[w]e look at the revenue that is lost and so we know the income that is

lost.” But lost revenue or lost income is not a proper basis for an award of lost

profit damages. Kellmann, 332 S.W.3d at 684. We therefore hold that the

testimony recited above does not provide a single complete calculation of Prexus’s

alleged lost profits.

The lack of a single complete calculation is further confirmed by the jury

charge. The jury charge asked two lost profits questions. The first asked: “The

amount [University General] agreed to pay Prexus for the [PSA] less the expenses

12

Prexus saved by not completing the [PSA].” The second lost profits question

asked: “The amount Ascension agreed to pay Prexus for the [CSA] less the

expenses Prexus saved by not completing the [CSA].” There were no objections

lodged to either lost profits question. In this circumstance, we measure the

sufficiency of the evidence according to the charge submitted to the jury. Romero

v. KPH Consol., Inc., 166 S.W.3d 212, 221 (Tex. 2005); Osterberg v. Peca, 12

S.W.3d 31, 55 (Tex. 2000).

The appellate record is devoid of any evidence demonstrating the expenses

Prexus saved by not completing the PSA or the CSA. Nor is there any evidence

from which the jury could determine how to apportion Mangal’s figures, which

addressed “the PSA and the CSA” together, in order to provide the separate

damage answers for each agreement that the verdict form required. For these

additional reasons, the evidence is insufficient to establish a single complete

calculation of lost profits from either the PSA or the CSA. See Kellmann, 332

S.W.3d at 686; Wiese v. Pro Am Serv., Inc., 317 S.W.3d 857, 863–64 (Tex. App.—

Houston [14th Dist.] 2010, no pet.).4

We reject Prexus’s argument that Griffin’s testimony somehow confirmed

the accuracy of Mangal’s $2.4 million figure as Prexus’s lost profits. Even if we

accept Griffin’s nebulous comment that he “did factor that” as confirmation he

4

On rehearing, Prexus argues a remand is required because evidence of damages that are

not segregated among claims is more than a scintilla of evidence of segregated damages. But the

problem we have described above is a failure of proof, not a failure to segregate. In the case

Prexus cites, the supreme court remanded because the jury had awarded lost profits to all four

plaintiffs as a single lump sum, and two of the plaintiffs were not entitled to recover. See Minn.

Mining & Mfg. Co. v. Nishika Ltd., 953 S.W.2d 733, 738–39 (Tex. 1997). In this case, however,

the jury charge segregated Prexus’s damages, providing separate answer blanks for the PSA and

CSA. The problem is that Prexus did not provide legally sufficient evidence of a complete lost

profits calculation for either contract. Because Prexus’s awards are neither unsegregated nor

supported by legally sufficient evidence, Nishika does not require a remand. Cf. id. at 739

(“When supported by legally sufficient evidence, an unsegregated damages award . . . ordinarily

requires a remand.”).

13

believed the $2.4 million figure referred to profit rather than revenue, he went on

to testify, when asked if he disagreed with that figure, that he did not know the

answer and could not tell the jury that number. This testimony confirms nothing

except Griffin’s lack of knowledge on this subject.

During oral argument, Prexus suggested the $2.4 million number was based

on the six months the PSA and the CSA were performed prior to appellants’

breaches. While basing a lost profits calculation on historic performance may be

acceptable in some circumstances, Mangal provided no testimony connecting his

$8 million and $2.4 million numbers to Prexus’s actual past performance under the

PSA and the CSA. See Spring Window Fashions Div., Inc. v. Blind Maker, Inc.,

184 S.W.3d 840, 884 (Tex. App.—Austin 2006, pet. granted, judgm’t vacated

w.r.m.) (stating that while there is no one correct method to calculate lost profits, it

is not enough to supply pieces of several different methods).

In an effort to establish a single complete calculation, and relying on the

Texas Supreme Court’s ERI Consulting opinion, Prexus points to Mangal’s

testimony that Prexus anticipated it would achieve a 32 percent profit margin if its

negotiations with the nascent Humble Hospital ever came to fruition. See ERI

Consulting, 318 S.W.3d at 876–77. Mangal testified the 32 percent figure was

based on the prior year’s financials. Even if we assume the number is accurate, it

was linked only to the profits Prexus estimated it would receive if and when its

contract with Humble Hospital was performed. There is no evidence in the record,

from Mangal or any other witness, providing a link between this expected 32

percent profit margin figure and the profit margin Prexus was earning on its PSA

with University General or its CSA with Ascension. In other words, no one

testified about the profit margin Prexus was earning on the two existing contracts

at issue here, and there is no evidence that the potential contract with Humble

14

Hospital was sufficiently similar to each of those contracts that Prexus would earn

the same profit margin on all three of them.5 As a result, we conclude the

anticipated Humble Hospital profit margin cannot serve as a basis for the required

single complete calculation of lost profits from the PSA and CSA. See Exel

Transp. Servs., Inc. v. Aim High Logistics Servs., LLC, 323 S.W.3d 224, 234 (Tex.

App.—Dallas 2010, pet. denied) (holding that evidence of lost profits must be

connected to the lost profits actually alleged to have been lost as a result of the

defendant’s conduct).

On rehearing, Prexus argues for the first time that there is sufficient evidence

linking the contracts, and it cites evidence it did not address in its pre-submission

brief. Appellate courts generally do not consider arguments raised for the first

time on rehearing. AVCO Corp. v. Interstate Sw., Ltd., 251 S.W.3d 632, 676 (Tex.

App.—Houston [14th Dist.] 2007, pet. denied) (supp. op. on reh’g).6 Nevertheless,

even these new record citations do not alter our conclusion that Prexus offered no

evidence linking the contracts.

Specifically, Prexus now points to testimony that: (1) the Humble Hospital

pro forma was indicative of the type of pro forma that Mangal reviewed in

evaluating whether to enter into a project; (2) University General and Humble

Hospital had some common shareholders; and (3) in creating a pro forma, Griffin

5

On rehearing, Prexus argues that its evidence of lost profits is nevertheless sufficient

under ERI Consulting. But the failure of proof we have identified above concerns an issue that

was not presented in ERI Consulting. The sole owner of ERI Consulting testified to its profit

margin on an existing contract with Merico, and the supreme court held this testimony sufficient

to support an award of lost profit damages on that same contract. ERI Consulting, 318 S.W.3d at

876. In this case, however, Prexus is attempting to support its awards of lost profit damages by

citing the profit margin it anticipated earning on a different potential contract without tying that

margin to the contracts at issue.

6

Moreover, we are not required to make an independent search of a voluminous record

for evidence supporting a party’s position. See Tex. R. App. P. 38.1(i), 38.2(a); Hakemy Bros.,

Ltd. v. State Bank & Trust Co., 189 S.W.3d 920, 927–28 (Tex. App.—Dallas 2006, pet. denied).

15

would “find out the volume that [the different physician specialists] could

potentially bring into a center like that,” would “use the net revenue data that we

had on other centers,” and “had a whole mechanism to screen to determine the

expense structures.” This testimony is no evidence that Prexus’s expected profit

margin on the Humble Hospital contract was the same as its existing profit margin

on either the University General or the Ascension contracts. Whether Prexus used

a certain type of pro forma to evaluate a potential project says nothing about

whether that project’s profitability will be the same as established projects, even if

the projects have some common shareholders. In addition, Griffin helped create

the Humble Hospital pro forma, but he did not prepare the final version and did not

know if the numbers had changed. Nor did he say that the net revenue data he

used in earlier versions came from the University General and Ascension contracts

specifically. Yet even if it did, there is no evidence that the physician specialists

included in the Humble Hospital pro forma had the same profitability as those

practicing at University General, or that the expense screening mechanism used in

the pro forma matched the expenses Prexus was incurring on the University

General and Ascension contracts. For these additional reasons, the Humble

Hospital pro forma does not provide sufficient evidence to support the jury’s

awards of lost profits on the University General and Ascension contracts.

Finally, we reject Prexus’s argument that we must accept the $8 million and

$2.4 million figures as conclusive evidence of Prexus’s lost profits because

appellants had the burden to come forward with contradictory evidence and failed

to meet that burden. In support of this contention, Prexus once again cites ERI

Consulting. 318 S.W.3d at 877 n.5. In ERI Consulting, the Supreme Court of

Texas stated that “the defendant properly bears the burden of providing at least

some evidence suggesting that an otherwise complete lost profits calculation is in

16

fact missing relevant credits.” Id. at 878 (emphasis added). That is not the

situation here because we have already held that Prexus did not provide a complete

lost profits calculation. Because Prexus never met its burden to introduce evidence

of a single complete calculation of lost profits, the burden never passed to

appellants to come forward with contradictory evidence.

For these reasons, we conclude the evidence is legally insufficient to support

the judgment’s awards of lost profit damages to Prexus. Therefore, we sustain

appellants’ second issue on appeal.

III. The proper remedy is to modify the judgment to delete the lost profit

damages, not to remand.

Generally, the proper legal remedy for legal insufficiency of the evidence is

rendition of judgment for the appellant. Vista Chevrolet, Inc. v. Lewis, 709 S.W.2d

176, 177 (Tex. 1986). Despite that general rule, Prexus asserts that, at most,

appellants are entitled to a remand for a new trial. In support of this contention,

Prexus cites numerous cases for the proposition that when there is legally sufficient

evidence of some ascertainable amount of damages, but not the amount awarded

by the jury, a take-nothing judgment is not proper. See, e.g., ERI Consulting, 318

S.W.3d at 880. We disagree that we are presented with such a situation. Instead,

as we have explained above, we have a situation where there is no competent

evidence establishing any amount of lost profits with reasonable certainty. Cf. id.

at 877–78 (holding remand required if plaintiff’s evidence is legally sufficient “to

prove a lesser, ascertainable amount of lost profits with reasonable certainty”). In

that situation, the general rule requires that we render judgment that Prexus take

nothing on its lost profits claims against appellants. See Kellmann, 332 S.W.3d at

686–87.

17

CONCLUSION

Having sustained appellants’ second issue, we modify the final judgment to

delete (1) the award of $900,000 in lost profits as a result of University General’s

breach of the PSA, and (2) the award of $1,200,000 in lost profits as a result of

Ascension’s breach of the CSA. We affirm the judgment as modified.

/s/ J. Brett Busby

Justice

Panel consists of Justices Frost, Boyce, and Busby.

18

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.